📑ADALIMUMAB LÍQUIDO PARENTERAL 40 MG
Procurement process summary
This process is to purchase Adalimumab líquido parenteral 40 mg.
This contract was awarded by 🇪🇨 ISSFA for an amount of USD 34,551 to 1 supplier. It was published on 2026-09-28 through open and its current status is active
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
Buying entity🇪🇨 ISSFA Buying unitnot reported Publication date2026-09-28 Contest statusactive DescriptionSIE-ISSFA-2026-022-2803Awards
This award was granted to LABORATORIOS LA SANTE COMPAÑIA LIMITADA by ISSFA for an amount of USD 34,551. The procurement process was conducted through open for the category of goods. The contract was signed on 2026-09-28. The award was granted on 2026-09-08.
| Supplier | Amount | Award date |
|---|---|---|
| 🇪🇨 LABORATORIOS LA SANTE COMPAÑIA LIMITADA | USD 34,551 | 2026-09-08 |
Market context and opportunities
The execution of this contract allows the entity ISSFA to fulfill its public service objectives efficiently.
The open purchase modality ensures that the process is transparent and compliant with regulations.
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
This transparency in public procurement promotes fair competition, prevents corruption, and ensures that public resources are used efficiently for the benefit of citizens.
Additional data
Contract NumberEC_ocds-5wno2w-SIE-ISSFA-2026-022-2803-2635272-SIE-ISSFA-2026-022Publication date2026-09-28Contract date2026-09-28Award date2026-09-08CategoriesgoodsPurchase modalityopenMethod detailsSubasta Inversa ElectrónicaStatusactiveData sources
Sociedad.info publishes data from official sources, in compliance with public information access laws. Public access to this data is a civic right that helps hold government accountable. This data, including names and identifiers, is already public in the official source. Read our privacy policy.
